Nervgen Pharma Corp (NGEN)
Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 0 | 1,220 | 1,840 | 2,050 | 1,450 |
| TOTAL | $N/A | $1,220 | $1,840 | $2,050 | $1,450 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 60,950 | 65,490 | 63,360 | 50,780 |
| TOTAL | $N/A | $60,950 | $65,490 | $63,360 | $50,780 |
| Total Assets | $N/A | $62,170 | $67,330 | $65,410 | $52,230 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 22,670 | 4,860 | 3,590 | 700 |
| Accounts payable and accrued liabilities | 0 | 20,320 | 15,600 | 13,390 | 7,720 |
| Other current liabilities | N/A | 6,710 | 5,230 | 8,890 | 620 |
| TOTAL | $N/A | $51,140 | $26,350 | $25,870 | $9,040 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 7,700 | 22,330 | 22,680 | 6,640 |
| TOTAL | $N/A | $26,750 | $22,330 | $22,680 | $6,640 |
| Total Liabilities | $N/A | $77,890 | $48,680 | $48,550 | $15,680 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 80 | 70 | 60 | 50 |
| Other shareholders' equity | 0 | 1,460 | 2,460 | -720 | -9,190 |
| TOTAL | $N/A | $447,800 | $442,110 | $428,310 | $386,150 |
| Total Liabilities And Equity | $0 | $525,690 | $490,790 | $476,860 | $401,830 |